Hetero launches its generic semaglutide portfolio in international markets, enhancing access to advanced diabetes and obesity therapies.
Hetero launches generic semaglutide portfolio in overseas markets
ਸਰੋਤ: Hindu Business Line
AI ਅਨੁਵਾਦਿਤ ਸਾਰ
ਟਿੱਪਣੀਆਂ (0)
ਲੌਗ ਇਨ ਗੱਲਬਾਤ ਵਿੱਚ ਸ਼ਾਮਲ ਹੋਣ ਲਈ।
ਅਜੇ ਕੋਈ ਟਿੱਪਣੀ ਨਹੀਂ। ਪਹਿਲੀ ਟਿੱਪਣੀ ਕਰੋ!
ਸੰਬੰਧਿਤ ਖ਼ਬਰਾਂ
'Sir, yeh memes band nahi hone chahiye': Raghav Chadha joins meme fest on his Parliament speeches
The 37-year-old Rajya Sabha MP from Punjab has been actively raising a range of everyday issues during the ongoing Budge...
Mint
•
•
1 ਮਿੰਟ ਪੜ੍ਹੋ
Housing sales in Jan-Mar dip 7% from December quarter due to West Asia conflict, up 9% annually: Anarock
Sales increased to 1,01,675 units during the current quarter from 93,280 units in the year-ago period
The Hindu
•
•
1 ਮਿੰਟ ਪੜ੍ਹੋ
30 Days of West Asia conflict: India ups LPG output, focuses on PNG as imports concerns persist
While India has “sufficient” stocks of crude oil, natural gas, petrol, diesel and jet fuel, it faces supply risk with re...
Hindu Business Line
•
•
1 ਮਿੰਟ ਪੜ੍ਹੋ
‘Humanitarian catastrophe’: While the world is focused on the war in Iran, something much worse is unfolding in Lebanon
Following the US-Israeli Operation Epic Fury against Iran, Israel's ground invasion of Lebanon has led to significant ci...
Mint
•
•
1 ਮਿੰਟ ਪੜ੍ਹੋ
Jaishankar raises concerns about food, fuel, fertilizer shortages at G-7 meet
External Affairs Minister stresses importance of resilient trade corridors, such as the IMEC, especially amidst uncertai...
The Hindu
•
•
1 ਮਿੰਟ ਪੜ੍ਹੋ
Hindu Business Line ਤੋਂ ਹੋਰ
30 Days of West Asia conflict: India ups LPG output, focuses on PNG as imports concerns persist
Hindu Business Line
·
Redefining identity and access
Hindu Business Line
·
Why the reduction in SED
Hindu Business Line
·
Iran war: Rupee closes at all-time low, bond yields harden, equities take a beating
Hindu Business Line
·
